KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

LARIAM 250 MG TABLETS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

250 MG

 

GENERIC NAME:

MEFLOQUINE

 

MANUFACTURER:

F. HUFFMANN LA ROCHE

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

C

 

INDICATIONS:

Malaria

Malaria, prophylaxis

 

SIDE EFFECTS:

Abnormal dreams

asthenia

forgetfulness

hypertension

hypotension

insomnia

Arrhythmia

cardiopulmonary arrest

central nervous system (CNS) disturbances or neuropsychiatric toxicity

convulsions

encephalopathy

erythema multiforme and/or Stevens-Johnson syndrome

leukopenia

thrombocytopenia

Abdominal pain

arthralgia and/or myalgia

diarrhea

dizziness

fever

headache

nausea

vomiting

Anorexia

Alopecia

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

>> Epilepsy

>> Seizure disorder

>> Heart block, first or second degree

>> Psychiatric disorders

 

ADULT DOSE:

Malaria (prophylaxis)- Oral, 250 mg once a week, starting one to two weeks before travel, then weekly during travel in malarious areas and for four weeks after leaving those areas . Malaria (treatment)- Oral, 1250 mg as a single dose, or 16.5 mg per kg of body weight as a single dose . Alternatively, 750 mg followed by 500 mg 8 hours later may be considered .

 

MAXIMUM ADULT DOSE:

 

PEDIATRIC DOSE:

Malaria (prophylaxis)- Infants and children up to 15 kg of body weight: Oral, 5 mg . Children 15 to 19 kg of body weight-Oral, 62.5 mg (1/4 tablet) once a week, starting one to two weeks before travel, then weekly during travel in malarious areas and for four weeks after leaving endemic areas . Children 20 to 30 kg of body weight-Oral, 125 mg (1/2 tablet) once a week, starting one to two weeks before travel, then weekly during travel in malarious areas and for four weeks after leaving endemic areas . Children 31 to 45 kg of body weight-Oral, 187.5 mg (3/4 tablet) once a week, starting one to two weeks before travel, then weekly during travel in malarious areas and for four weeks after leaving endemic areas . Children over 45 kg of body weight-See Usual adult and adolescent dose . Malaria (treatment)- See Usual adult and adolescent dose . 

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT